PDS Biotechnology Files 8-K with Exhibits
Ticker: PDSB · Form: 8-K · Filed: Apr 15, 2026
Sentiment: neutral
Topics: filing, exhibit, sec
TL;DR
PDS Biotech filed an 8-K, check exhibits for news.
AI Summary
PDS Biotechnology Corporation filed an 8-K on April 15, 2026, reporting other events and financial statements/exhibits. The filing includes an exhibit (EX-99.1) and XBRL data, but does not detail specific business events or financial figures within the provided text.
Why It Matters
This filing indicates PDS Biotechnology is providing updated information or exhibits to the SEC, which could contain material details for investors.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for other events and exhibits, with no immediate indication of significant negative or positive developments.
Key Players & Entities
- PDS Biotechnology Corp (company) — Filer
- 0001472091 (company) — CIK Number
- 2026-04-15 (date) — Filing Date
FAQ
What specific events are being reported under Item 8.01?
The provided text for the 8-K filing does not specify the details of the 'Other Events' reported under Item 8.01.
What is contained in Exhibit 99.1?
Exhibit 99.1 is listed as part of the filing documents, but its specific content is not detailed in the provided text.
What is the CIK number for PDS Biotechnology Corp?
The CIK number for PDS Biotechnology Corp is 0001472091.
When was this 8-K filing accepted by the SEC?
This 8-K filing was accepted by the SEC on April 15, 2026, at 08:55:12.
What is the SIC code for PDS Biotechnology Corp?
The SIC code for PDS Biotechnology Corp is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2026 regarding PDS Biotechnology Corp (PDSB).